1. Innovation in the pharmaceutical industry: new estimates of R&D costs;DiMasi;J. Health Econ.,2016
2. Phase II and phase III failures: 2013–2015;Harrison;Nat. Rev. Drug Discov.,2016
3. World Health Organization Quality Assurance and Safety of Medicines Team, Safety of medicines: a guide to detecting and reporting adverse drug reactions: why health professionals need to take action., (2002).
4. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies;Kongkaew;Ann. Pharmacother.,2008
5. Drug-induced liver injury: an overview over the most critical compounds;Björnsson;Arch. Toxicol.,2015